Pharma and healthcare mutual funds have yielded impressive returns in 2024. The sector benefited from resilience amidst corrections in other sectors and steady growth in the domestic market. Experts suggest a cautious approach to investment due to current valuations. A phased allocation strategy of 10-15% is recommended, with potential for increasing allocation over time.
MGL rides PNG adoption wave, analysts see further upside
Mahanagar Gas shares have surged on government’s push for piped natural gas adoption, aiming for a 20% customer base increase. This move is expected to